Overview

Beta-1 Adrenergic Inhibition to Reduce Cardiac Injury and Inflammation After Subarachnoid Hemorrhage (BADCATS)

Status:
RECRUITING
Trial end date:
2029-09-01
Target enrollment:
Participant gender:
Summary
To determine the effect of early metoprolol administration after non-traumatic subarachnoid hemorrhage (SAH).
Phase:
PHASE4
Details
Lead Sponsor:
Madeleine Puissant
Collaborator:
MaineHealth
Treatments:
Metoprolol